A person with diabetes may need evaluation by a kidney specialist (nephrologist) when urine albumin remains elevated, kidney filtration declines, creatinine changes unexpectedly, blood pressure is difficult to control or the cause of abnormal kidney tests is uncertain.
Diabetes can damage the kidneys gradually, often without noticeable symptoms. However, not every abnormal kidney test requires immediate specialist referral, and not every kidney problem in someone with diabetes is caused by diabetes.
Regular assessment using the urine albumin-to-creatinine ratio (uACR) and estimated glomerular filtration rate (eGFR) helps detect kidney abnormalities and identify individuals who may benefit from additional investigations.
This article explains when nephrology assessment may be appropriate, which test results matter, how kidney disease is evaluated and what symptoms require urgent medical attention.
The kidneys contain millions of microscopic filtering units called nephrons.
Within each nephron, the glomerulus helps filter waste products and excess fluid from the bloodstream while retaining most essential proteins.
Over time, elevated blood glucose can damage small blood vessels and affect these filtering structures.
Possible consequences include:
Increased albumin leakage into urine.
Changes in the kidney’s filtering ability.
Reduced eGFR in some individuals.
Fluid and electrolyte disturbances as kidney dysfunction advances.
Development or progression of chronic kidney disease (CKD).
High blood pressure can further contribute to kidney damage.
Kidney disease associated with diabetes is commonly called diabetic kidney disease (DKD).
However, some people with diabetes develop kidney abnormalities from other causes, including glomerular diseases, urinary obstruction or medication-related kidney injury.
For more information, read Diabetic Kidney Disease Symptoms.
Early diabetic kidney disease often has no noticeable symptoms.
A person may have:
Normal-looking urine.
No swelling or pain.
No obvious change in urination.
Serum creatinine within the laboratory reference range.
Relatively preserved eGFR.
Despite this, urine testing may reveal increased albumin.
Other people may develop reduced filtration without increased urine albumin.
Therefore, urine ACR and eGFR provide complementary information about kidney health.
Blood pressure, diabetes history, previous reports and other clinical findings also contribute to assessment.
Nephrology evaluation may be appropriate when kidney abnormalities are significant, progressive, difficult to explain or associated with complications.
Albumin is a protein normally retained in the bloodstream.
An increased urine ACR indicates that more albumin than expected is being detected in urine.
Persistent albuminuria may indicate kidney damage, even when eGFR remains relatively preserved.
However, one elevated result does not automatically mean diabetic kidney disease is present.
Repeat testing may be necessary because urinary albumin can temporarily increase during fever, infection, strenuous exercise or other medical conditions.
Nephrology evaluation may be particularly relevant when albuminuria is severely increased, rises rapidly or remains unexplained.
eGFR estimates how effectively the kidneys filter blood.
A sustained decline may indicate worsening kidney function.
The rate of change, previous results, accompanying urine findings and other medical factors are important.
A single slightly reduced eGFR does not automatically require immediate specialist referral.
However, a progressive or unexplained decline may warrant nephrology assessment.
Serum creatinine is a blood marker used to estimate kidney filtration.
An elevated result may occur with acute kidney injury, chronic kidney disease, dehydration, certain medicines or other medical conditions.
An unexpected rise should be assessed according to its degree, timing and associated symptoms.
Rapid changes may require urgent clinical assessment rather than routine follow-up.
Hypertension can contribute to kidney damage and may also develop or worsen because of kidney disease.
Specialist evaluation may be appropriate when blood pressure remains difficult to control despite an appropriately assessed treatment plan, particularly when kidney abnormalities are present.
Individual blood pressure targets depend on medical history, treatment tolerance and other clinical circumstances.
Proteinuria accompanied by hematuria (blood in urine) can sometimes suggest a glomerular disorder.
Additional investigation may be needed, especially when urine microscopy shows concerning findings or kidney function is declining.
Blood in urine may also have causes outside the kidneys, so evaluation should consider possible urinary tract conditions.
Reduced kidney function can affect the balance of potassium, sodium and bicarbonate.
Certain treatments can also influence these measurements.
Significant abnormalities, especially elevated potassium or acid–base disturbances, may require specialist assessment.
Severe electrolyte disturbances can be medical emergencies.
People with advanced CKD may benefit from nephrology assessment for complications, medication review, disease monitoring and discussion of possible future treatment needs.
An eGFR below 30 mL/min/1.73 m² is a commonly recognised reason to consider nephrology referral, although referral may be appropriate at higher eGFR levels depending on the clinical situation.
Diabetes is an important cause of CKD, but it is not the only cause.
Another diagnosis may be considered when there is:
Sudden deterioration in kidney function.
Rapidly increasing proteinuria.
Blood in urine with concerning microscopic findings.
Nephrotic syndrome.
Other findings suggesting immune-mediated or structural kidney disease.
Kidney abnormalities that do not fit the expected clinical pattern.
Further blood tests, imaging or occasionally kidney biopsy may be considered when clinically indicated.
Kidney function evaluation commonly combines blood tests, urine investigations and blood pressure assessment.
| Test | What it measures | Why it matters |
|---|---|---|
| Serum creatinine | Creatinine concentration in blood | Helps estimate kidney filtration |
| eGFR | Estimated kidney filtering function | Helps identify reduced filtration |
| Urine ACR | Albumin relative to creatinine in urine | Helps detect albumin leakage |
| Urinalysis | Blood, protein and other urine findings | Helps identify additional abnormalities |
| HbA1c | Average blood glucose over approximately 2–3 months | Supports diabetes management |
| Blood pressure | Pressure within the arteries | Helps evaluate hypertension-related risks |
| Electrolytes | Potassium, sodium and bicarbonate concentrations | May identify kidney-related complications |
Not every patient requires all these tests at the same frequency.
Testing should be based on individual medical circumstances.
Read more about Kidney Tests Explained.
Urine ACR is commonly expressed in milligrams of albumin per gram of creatinine (mg/g).
| Urine ACR | Category | Interpretation |
|---|---|---|
| Below 30 mg/g | A1 | Normal to mildly increased |
| 30–299 mg/g | A2 | Moderately increased albuminuria |
| 300 mg/g or above | A3 | Severely increased albuminuria |
No.
A urine ACR of 30 mg/g or above indicates increased albuminuria, but the need for specialist referral depends on persistence, severity, kidney function and other clinical findings.
A single abnormal result may require repeat testing before its long-term significance is established.
Urinary albumin levels can vary.
Temporary factors may include fever, infection, strenuous exercise, marked hyperglycaemia and menstruation-related contamination.
In people with diabetes, persistent moderately or severely increased albuminuria is commonly confirmed using at least two abnormal results among three measurements collected over approximately three to six months.
The timing should be individualised when more significant findings require earlier evaluation.
Read Urine ACR Test Explained for further information.
eGFR is commonly reported in mL/min/1.73 m².
| eGFR | Category | General description |
|---|---|---|
| 90 or above | G1 | Normal or high |
| 60–89 | G2 | Mildly decreased |
| 45–59 | G3a | Mildly to moderately decreased |
| 30–44 | G3b | Moderately to severely decreased |
| 15–29 | G4 | Severely decreased |
| Below 15 | G5 | Kidney failure range |
G1 and G2 alone do not establish CKD unless another marker of kidney damage is present.
CKD generally involves kidney abnormalities persisting for at least three months.
No.
An eGFR below 60 may indicate reduced filtration, but its significance depends on the duration, rate of decline, urine ACR and accompanying findings.
For example, stable stage G3a CKD may be managed with appropriate monitoring in some circumstances, while rapidly deteriorating results can warrant earlier specialist assessment.
No.
Although an eGFR below 15 falls within the kidney failure range, dialysis is not initiated based on one numerical result alone.
The decision depends on symptoms, complications, fluid balance, laboratory findings and overall clinical assessment.
For more information, read When Is Dialysis Needed?.
Yes.
Serum creatinine reflects aspects of overall kidney filtration but does not directly measure albumin leakage.
Some people have normal-range creatinine while urine ACR is elevated.
Others may have relatively preserved filtration and still show evidence of persistent kidney damage.
Therefore, serum creatinine alone may not identify early diabetic kidney disease.
Urine ACR and eGFR should be interpreted together.
Learn more about Diabetic Kidney Disease With Normal Creatinine.
The American Diabetes Association Standards of Care in Diabetes—2026 recommends regular assessment using urine ACR and eGFR.
For adults with type 1 diabetes, annual urine ACR and eGFR testing is generally recommended after five years of diabetes duration.
Earlier evaluation may be indicated in selected circumstances.
For adults with type 2 diabetes, urine ACR and eGFR are generally assessed at least annually from diagnosis, regardless of treatment.
People with CKD may require urine ACR and eGFR testing approximately one to four times per year, or more frequently when clinically indicated.
Monitoring frequency depends on CKD severity, progression risk, medicines and associated conditions.
Children and adolescents require age-appropriate screening recommendations.
A kidney assessment may involve several steps.
Relevant details may include:
Type and duration of diabetes.
Previous blood glucose results.
Blood pressure history.
Current medicines and supplements.
Previous kidney test reports.
Family history of kidney disease.
Other medical conditions.
Recent acute illness.
Depending on the circumstances, examination may include blood pressure assessment, evaluation of swelling and other signs related to fluid balance or systemic illness.
Previous creatinine, eGFR and urine ACR results help establish whether kidney abnormalities are stable, improving or progressing.
Selected patients may require:
Urine microscopy.
Urine protein-to-creatinine ratio.
Kidney ultrasound.
Autoimmune or infection-related investigations.
Other specialised testing.
Kidney biopsy when tissue examination is likely to influence diagnosis or treatment.
A kidney biopsy is not routinely necessary for every person with diabetic kidney disease.
The following records can help provide clinical context.
| Report or information | Why it may help |
|---|---|
| Previous creatinine and eGFR | Helps identify kidney function trends |
| Urine ACR reports | Helps evaluate albuminuria |
| HbA1c or glucose records | Supports diabetes assessment |
| Blood pressure readings | Helps review hypertension |
| Current medicine list | Supports medicine safety assessment |
| Urinalysis | May identify blood or other abnormalities |
| Previous kidney imaging | Provides structural information if available |
| Relevant medical history | May help clarify contributing causes |
Not all records or investigations are necessary for every person.
A fixed requirement to check blood pressure three times daily is not appropriate for everyone.
Management depends on the underlying diagnosis, kidney function, albuminuria and individual medical needs.
Appropriate blood glucose management may reduce the risk of diabetes-related complications.
HbA1c targets should be individualised.
Controlling high blood pressure is important for kidney and cardiovascular health.
Targets and medicines should be selected based on medical history and treatment tolerance.
Certain medicines may reduce CKD progression or cardiovascular risk in eligible patients.
These may include ACE inhibitors, ARBs, SGLT2 inhibitors, GLP-1 receptor agonists and other treatments when clinically appropriate.
Medication choice depends on diabetes type, kidney function, albuminuria and potential adverse effects.
Monitoring of kidney function and electrolytes may be required.
Individualised measures may include reducing excessive sodium intake, avoiding tobacco, appropriate physical activity, weight management when indicated and reviewing non-prescription medicines.
Protein, potassium or fluid restrictions are not necessary for every person with diabetic kidney disease.
No treatment guarantees complete reversal of kidney damage or prevention of kidney failure.
Patients should not independently start, stop or change prescribed medicines.
No.
Many people with diabetic kidney disease do not require dialysis.
The need for dialysis depends on severe kidney dysfunction together with symptoms or complications that cannot be adequately managed by other means.
Nephrology assessment may help with planning when advanced CKD develops, but referral does not mean dialysis is immediately necessary.
Seek emergency medical care immediately for:
Severe shortness of breath.
Chest pain.
Confusion or loss of consciousness.
Seizures.
Very little or no urine output accompanied by significant illness.
Rapidly worsening swelling with difficulty breathing.
Visible blood in urine, severe flank pain with fever, persistent vomiting or unexpectedly rapid changes in kidney function may also require timely evaluation.
These symptoms can have several causes and should not automatically be attributed to diabetic kidney disease.
Patients may find it helpful to understand the following points:
What do the current urine ACR and eGFR results indicate?
Have these results changed compared with previous tests?
Is diabetes the likely cause, or should another kidney condition be considered?
Are any additional investigations required?
Could existing medicines affect kidney function or potassium?
How often should kidney tests be repeated?
What findings would require more urgent assessment?
Are there any individual dietary or fluid recommendations?
These questions support informed discussions rather than prescribing one management plan for everyone.
Nephrology evaluation may be appropriate when urine albumin is significantly or persistently elevated, eGFR declines, creatinine changes unexpectedly, blood pressure is difficult to control or the cause of kidney abnormalities is uncertain.
No. Many people with diabetes undergo routine kidney screening without requiring immediate specialist referral. The need depends on kidney findings, progression and other clinical factors.
Yes. Increased urine albumin may occur while serum creatinine remains within the laboratory reference range.
Not necessarily. Its importance depends on whether the reduction is new, persistent, stable or rapidly progressing, along with other clinical findings.
No. Urine albumin can increase because of other kidney disorders or temporary medical conditions. Repeat testing and clinical assessment may be needed.
Adults with type 2 diabetes generally require urine ACR and eGFR at least annually from diagnosis. For adults with type 1 diabetes, annual testing generally begins after five years. Some patients require more frequent monitoring.
No. Specialist evaluation may help identify the cause of abnormalities and guide management. Dialysis is considered only when clinically indicated.
Severe breathlessness, chest pain, confusion, seizures, or markedly reduced urine output with significant illness require emergency medical attention.
Diabetes can affect kidney health before noticeable symptoms develop.
Urine ACR and eGFR are important complementary tests for identifying albumin leakage and changes in kidney filtration.
Nephrology evaluation may be appropriate when abnormalities are significant, progressive, unexplained or accompanied by complications.
However, not every mildly abnormal result requires immediate specialist referral, and diabetes is not necessarily the cause of every kidney problem.
Individual medical assessment helps determine whether further investigations, treatment adjustments or ongoing monitoring are appropriate.
Medical Information: Dr. Jyoti Bansode | MBBS, MD Medicine, DM Nephrology | Medical Registration No.: 2011/06/1863 | Maharashtra Medical Council (MMC).
Medical Disclaimer: Website content and visuals are for general informational, educational and representational purposes only, may not reflect individual patient conditions or outcomes, and do not replace personalised medical advice, diagnosis or clinical assessment.